Xov xwm

Cov Txiaj Ntsig Zoo Kawg Nkaus ntawm CD7-Targeted CAR-T Therapy rau T-ALL thiab T-LBL
Tsis ntev los no, ib txoj kev tshawb fawb qhia txog cov txiaj ntsig zoo ntawm CD7-targeted chimeric antigen receptor (CAR) T cell therapy hauv kev kho cov neeg mob uas rov qab mob lossis tsis kho tau T-cell acute lymphoblastic leukemia (T-ALL) thiab T-cell lymphoblastic lymphoma (T-LBL).

Kev Them Nqi ntawm 2024 ASH Lub Rooj Sib Tham Txhua Xyoo thiab Kev Nthuav Qhia
Lub Rooj Sib Tham Txhua Xyoo 66th ntawm American Society of Hematology (ASH) yuav muaj nyob rau txij lub Kaum Ob Hlis 7-10, 2024, ntawm San Diego Convention Center, uas qhia txog kev tshawb fawb tshiab thiab kev nce qib hauv hematology.

Tshaj tawm xyoo 2024 Lub Rooj Sab Laj Txog Kev Mob Ntshav Lu Daopei Txhua Xyoo thaum Lub Yim Hli
Lub Rooj Sab Laj Txog Kev Mob Ntshav Xyoo 12th Lu Daopei tau teem sijhawm yuav muaj nyob rau lub Yim Hli 23-24, 2024, ntawm Beijing International Convention Center. Koom nrog peb rau kev sib tham txog kev nkag siab thiab kev nce qib tshiab hauv kev kho mob ntshav.

Kev Cia Siab Tshiab hauv Kev Kho Mob Cancer: TILs Therapy Tawm Tsam Ua Tus Ciam Teb Tom Ntej
Txawm hais tias muaj kev cov nyom hauv kev lag luam thiab kev lag luam, CAR-T therapy cov kev txwv tau raug daws los ntawm txoj hauv kev tshiab zoo: Tumor-Infiltrating Lymphocyte (TIL) therapy. Qhov kev tshawb pom no qhia txog lub sijhawm tshiab hauv kev sib ntaus tawm tsam cov qog nqaij hlav khov kho.
Cov Kev Kho Mob Cellular puas yog Yav Tom Ntej ntawm Kab Mob Autoimmune?
Ib txoj kev kho mob tshiab rau mob qog noj ntshav kuj tseem yuav kho tau thiab pib dua lub cev tiv thaiv kab mob kom rov zoo li qub lossis tej zaum yuav kho tau qee yam kab mob autoimmune.

Xyoo 2023 ASH Qhib | Dr. Peihua Lu Nthuav Qhia CAR-T rau Kev Tshawb Fawb Txog AML Rov Qab Los / Refractory

ASH 2023 | "Lub Suab ntawm Lu Daopei" hu nkauj rau ntawm theem thoob ntiaj teb











